Tag: startup funding india

Jedify builds software that gives enterprise AI agents a live map of a company’s data, documents, permissions, and business language. That pitch just helped the New York startup land a $24 million Series A led by Norwest, at a moment when a lot of enterprise AI still looks smarter in demos than it does inside real companies. Founded by Assaf Henkin, Adi Elimelech, and Erik Shani, Jedify was founded in 2023 and launched its Semantic Fusion platform in 2024. The bet is pretty simple: AI agents don’t fail because the model is weak. They fail because they don’t understand the business they’re dropped into.

What is Jedify’s context graph for enterprise AI?

Jedify’s core product is a context layer that sits between enterprise systems and AI agents. A customer connects sources like databases, warehouses, SaaS apps, BI tools, docs, Slack, and other unstructured content. Jedify then builds a context graph, using its Semantic Fusion engine to connect entities and metrics. It also ties in permissions, workflows, and company-specific definitions into something an agent can reason over.

The workflow is more concrete than the usual “we organize your knowledge” pitch. In the docs, Ask Jedify breaks a user request into entities, metrics, time frames, filters, and groupings, maps those terms to the company’s semantic model, and then composes SQL to fetch the answer. That means a sales leader can ask a plain-English question about pipeline, win rate, or revenue and get a response grounded in internal definitions rather than whatever the model guesses “revenue” should mean.

Jedify also packages that layer into several product modules. There’s Ask Jedify for conversational analytics. There’s a Contextual MCP Server that plugs business context into outside agent frameworks, plus Smart Scenarios for recurring deliverables like QBR decks and reports, and an Insights Library for reusable prompts and shared analysis. The docs also show Slack and Looker integrations, which hints at where the company wants to live: inside the tools employees already use, not as another standalone analytics tab.

That setup helps explain the Kiteworks example in the source article. Kiteworks connected Snowflake, Tableau, Notion, and internal playbooks — including screenshots and documents — then used Jedify to build seller-facing and account-team workflows. Henkin’s description is basically a real-time prep layer for customer calls. The system assembles what the rep needs before a meeting, then surfaces specific details during the conversation itself.

Who founded Jedify and what’s its early traction?

Founding story

The founders have worked together around data and AI for more than 15 years. They previously built one of the earlier open-source intelligence platforms used by large organizations, then went on to run Singtel’s digital data business after that company was acquired. That history matters because Jedify isn’t coming from a pure research angle. It’s coming from people who’ve already lived through messy enterprise data sprawl.

Jedify’s formal story starts in 2023. The trio had watched dashboards, semantic layers, and catalogs pile up while enterprise data got more fragmented and more unstructured. Semantic Fusion — launched in early 2024 — is their answer.

Founder market fit

Henkin is the clearest public signal here. Before Jedify, he co-founded Kontera, a big-data consumer analytics company that Singtel acquired, and later helped build life-insurtech company Sproutt as co-founder, president, and COO. His background is heavy on data products, analytics, and operating inside large organizations after acquisition. That’s the kind of experience you’d want if you’re selling deep infrastructure into enterprises.

Shani, Jedify’s CPO, brings more product and go-to-market muscle. He was previously co-founder and chief product officer at Fyllo, a compliance-focused martech company, and his professional profile centers on strategy, product management, sales, and GTM work. That’s useful because Jedify isn’t just building a graph database with nice branding. It’s trying to turn a hard technical layer into a product business.

Elimelech, the CTO, appears to be the technical architect behind the company’s semantic and agent stack. He’s the co-author attached to Jedify’s deeper product explainers on agentic analytics and the autonomous context graph, which lines up with his role as the person translating the thesis into product architecture.

Traction and operating signals

Jedify is still early, but it’s not pre-product. Henkin said the company has between 10 and 20 early customers, including The Weather Company, and is seeing demand from gaming, industrials, and consumer packaged goods. LinkedIn lists the company at 11-50 employees, which fits the picture of a startup that’s past the prototype phase but still small enough to be highly hands-on with deployments.

The product stack also looks live, not aspirational. Jedify has published docs for its conversational analytics product, Smart Scenarios, MCP integrations, Slack app, Looker extension, and a Deep Research Agent. That doesn’t prove scale. But it does show a working platform rather than a single flashy demo.

Fundraising details

The new round is a $24 million Series A led by Norwest. Returning investors S Capital VC and Cerca Partners joined again, with Oceans Ventures added as a new backer. Snowflake came in as a strategic investor and is integrating Jedify with Cortex AI, Semantic Views, and CoWork. The fresh capital will go to product development and hiring. It will also fund go-to-market. Total funding is now about $33 million.

Competition and market positioning

This is where Jedify gets interesting — and where the pitch gets tougher.

Glean now pushes its own Enterprise Graph as the layer that captures relationships across people, projects, teams, and processes for enterprise AI. Moveworks pairs agentic search with a conversational assistant that reaches across connected business systems. Contextual AI, meanwhile, sells an enterprise platform for building specialized RAG agents over structured and unstructured data. Jedify is entering a crowded zone where everyone agrees context matters. They just disagree on where that context layer should live.

Jedify’s differentiation is narrower and more technical. Henkin argues it goes beyond a semantic layer or metadata catalog because it combines structured data and unstructured knowledge. It also pulls business rules and permissions into one graph that updates continuously. Unlike the “just bring everything into our cloud” logic from big platform vendors, Jedify is pitching itself as multi-system and model-agnostic. That’s a good argument if buyers don’t want one warehouse or one AI vendor to own the full control plane. It’s also a risky one, because Snowflake is both a partner and proof that the larger platforms are marching toward the same goal.

Why does this context graph for enterprise AI round matter?

The obvious answer is money. The more useful answer is timing.

A $24 million Series A tells you Jedify’s backers think the company has a shot at becoming infrastructure, not just another workflow app bolted onto an LLM. That matters because infrastructure companies can survive model churn. If Anthropic, OpenAI, Google, or open models keep leapfrogging each other, the value may shift toward the layer that knows how a business actually works.

Snowflake’s involvement sharpens that point. Strategic checks can be cosmetic. This one looks more substantive because it comes with product integration into Cortex AI, Semantic Views, and CoWork. If that integration turns into real distribution, Jedify gets an easier path into data teams that already trust Snowflake. If it doesn’t, Jedify still has the harder but more durable pitch: it helps enterprises stitch together the stuff that never lived in one platform to begin with.

There’s a customer angle here too. Enterprises are starting to get impatient with generic copilots that answer nicely but can’t reliably act. Jedify is selling the less glamorous layer underneath — permissions, entity relationships, metric definitions, governance, observability. That’s the kind of plumbing buyers complain about at first and then refuse to live without once it works.

How big is the context graph for enterprise AI market?

The demand side is real. Gartner forecast worldwide AI spending will hit $2.59 trillion in 2026, up 47% year over year, even as enterprises stay selective and favor practical deployments over moonshot transformation projects. That’s a useful backdrop for Jedify because it suggests buyers still want AI spend tied to measurable workflow gains, not abstract model bragging rights.

The more direct market is smaller but rising fast. Grand View Research estimates the enterprise knowledge graph market was about $2.89 billion in 2025 and could reach $13.37 billion by 2033, a 21.3% CAGR. Put differently: the industry is finally spending real money on the missing layer between raw enterprise data and AI systems that are supposed to do something useful with it.

Final take on Jedify’s enterprise AI context graph

Jedify isn’t promising a magic agent. It’s selling the context graph for enterprise AI that those agents need before they stop embarrassing themselves in production.

That’s a smarter pitch than most. The next question is whether Jedify can turn early design-heavy deployments into a repeatable product and keep its edge while bigger platforms build their own context layers.

Read how Exponent Energy raised ₹200 crore to expand its rapid-charging platform for commercial EVs, using a full-stack system that combines batteries, chargers, and energy management to cut charging times and keep fleet vehicles moving.

FAQ

• What funding did Jedify raise? Jedify raised a $24 million Series A. Norwest led the round, with S Capital VC and Cerca Partners returning, Oceans Ventures joining, and Snowflake investing strategically as part of a broader product integration plan.
• How does Jedify’s product actually work? It connects enterprise systems through APIs and builds a semantic context graph. That layer helps AI agents reason over business-specific data and definitions. In practice, the platform can turn plain-English questions into structured queries. It can also generate recurring reports and feed outside agents through its Contextual MCP Server.
• Who are Jedify’s founders? Jedify was founded by Assaf Henkin, Adi Elimelech, and Erik Shani. Henkin previously co-founded Kontera and later Sproutt, while Shani previously co-founded Fyllo. The team has spent more than 15 years building around data and AI.
• Is Jedify an enterprise search company or an AI infrastructure company? It looks closer to AI infrastructure than classic enterprise search. The company is building a context layer for agents — one that spans structured data, unstructured knowledge, permissions, and semantic definitions — which puts it nearer to the enterprise knowledge graph and agent-enablement category than to a simple search box.

Hoola Health runs neighbourhood paediatric clinics in Bengaluru, and this funding news matters because the startup is trying to fix a common problem: everyday child healthcare in India is still scattered across big hospitals, solo clinics, and one-off therapy centres. The company has raised $5 million in a round led by Peak XV’s Surge, with W Health Ventures and angels Ashish Gupta, Abhishek Goyal, and Bijou Kurien also backing the round. Founded in Bengaluru in 2024 by Deeksha Senguttuvan, the startup will use the money for new-market expansion, its tech stack, and scaling its integrated care model.

Here’s the pitch in one line: don’t send parents into a giant hospital for routine vaccinations and consults. Growth checks and therapy follow-ups can happen at a child-first clinic.

What is Hoola Health and how does it work?

Hoola Health — formerly BabyMD — is building a full-stack paediatric care model with offline clinics at the centre and digital continuity around them. A parent can book an in-clinic visit or use online consults. They can keep track of vaccinations and growth, then return for developmental assessments or therapy inside the same care setup instead of bouncing between unrelated providers. The company is also building digital records for vaccinations and prescriptions. It also tracks growth and developmental progress.

The care menu is broader than a standard neighbourhood paediatric clinic. Besides consultations and vaccinations, BabyMD’s service pages describe developmental assessments and speech and behavioural support. It also offers occupational therapy, nebulisation, allergy screening, sleep support, mental well-being counselling, nutrition help, and lactation support. That turns Hoola from a “see the doctor when the baby has a fever” business into a repeat-use care model that can stay relevant over years, not days.

The customer experience is designed to feel less clinical. The clinics are open 7 days a week, and the company handles records and follow-ups. Its ₹999-a-year membership plan offers priority booking and online consult access. It also includes discounts and a dedicated care manager who handles reminders and check-ins. That’s a smart detail. Parents don’t just need a doctor; they need the admin mess taken off their plate.

There’s also a basic operational choice that says a lot about the brand: well-baby visits are physically separated from sick-baby visits to reduce cross-infection risk. Its earlier positioning also included 24/7 AI-assisted access to doctors and specialists. That combination — clinic plus digital touchpoints plus continuity — makes Hoola more ambitious than a regular paediatric OPD.

Who founded Hoola Health and what traction does it have?

The founding story

Senguttuvan started BabyMD in 2024 after years in healthcare and technology, and her framing is simple: parents were stuck choosing between crowded hospitals with long waits and fragmented local care that rarely went beyond the basics. The company began with one clinic and a promise to make paediatric care feel “closer, calmer, and kinder.” The origin story fits the product now — a neighbourhood clinic model built around repeat use, not hospital-level drama.

The rebrand to Hoola Health is also telling. BabyMD worked if the business was mostly about infants and newborn support. Hoola is meant to stretch across more stages of childhood, and the company wants to serve children across a wider arc of growth.

Why Senguttuvan looks like a credible builder

Senguttuvan isn’t a first-principles outsider learning healthcare from scratch. Before BabyMD, she was Head of Digital Transformation at Kauvery Hospital, where she worked on patient engagement and operational readiness. Earlier, she held product and strategy roles at Tata Communications and spent time in Tata group management tracks. She also brings a strong academic résumé: Wharton for her MBA, IIM Kozhikode for management studies, and NIT Tiruchirappalli for engineering.

That mix matters here. Hoola isn’t just a clinic roll-up. It needs consumer empathy and healthcare ops discipline. It also needs enough product sense to make records, scheduling, follow-ups, and remote access actually work. Senguttuvan’s background fits that brief better than a founder coming purely from finance or generic consumer internet.

The early signals

Hoola already serves more than 20,000 families and gets more than 60% of monthly visits from returning families. More than 60% of new patients come in through word of mouth, which is one of the few growth channels that really means something in primary care. Nearly 35% of revenue comes from developmental therapies. That’s a useful clue.

The company currently operates five clinics in Bengaluru, with centres listed in Bellandur, Electronic City, HSR Layout, Kasavanahalli Road, Varthur, and Yelahanka. The next target is aggressive: 30 more clinics across Bengaluru, Hyderabad, and Delhi NCR over the next 2 years. That’s a real expansion plan, not a vague national-growth line.

The round and the rivals

This round brings in $5 million from Peak XV’s Surge, alongside existing backer W Health Ventures and angels Ashish Gupta, Abhishek Goyal, and Bijou Kurien. The cash will go toward entering new markets and upgrading technology. It will also help scale the integrated care model the company is already using in Bengaluru.

On direct competition, Hoola isn’t alone. Butterfly Learnings has built a more developmental-therapy-heavy model and raised Rs 32 crore in a Series A round in April 2024, while Gurugram-based Babynama raised $700,000 in February 2025 with a more digital-first paediatric care pitch. The legacy alternative, though, is still bigger than either startup competitor: parents piecing together hospital OPDs, local paediatricians, and separate therapy providers. Hoola’s bet is that integrated, recurring care in a child-first clinic can beat that patchwork on convenience and retention.

Why does Hoola Health funding matter now?

The obvious reason is footprint. Hoola wants to go from a Bengaluru network to a multi-city business, and physical clinics are expensive. You need doctors and therapists. You also need local ops, scheduling systems, inventory discipline, and enough patient density to keep each centre productive. This round gives the company room to do that without pretending software alone can solve paediatric care.

But the more interesting part is the revenue mix. A clinic chain built mostly on one-off consults can look busy and still be fragile. Hoola’s repeat visits and therapy revenue suggest something stronger — a family relationship business. That’s probably what investors are buying: predictable repeat behaviour and more services per household. The model can also deepen over time as children age.

There’s a brand point here too. Senguttuvan has said paediatric care in India has been “fragmented for too long,” and that parents don’t want to go through a hospital for routine consultations and vaccinations. Hoola’s answer is “neighbourhood clinics where clinical excellence and a human experience go hand in hand.” It’s a good line. The hard part now is proving that the warmth scales with the footprint.

Is India ready for more child-first clinics like Hoola Health?

The market tailwind is real, even if different reports measure different slices of it. IMARC estimates India’s pediatric healthcare market reached $461.3 million in 2025 and could grow to $680.8 million by 2034. Grand View Research, looking specifically at pediatric hospitals, pegs the India market at $5.275 billion in 2023 and projects it to reach $8.004 billion by 2030, with 6.1% CAGR. However you cut it, parents are spending more on specialised child health and providers are building more focused capacity around it.

Policy is moving in the same direction. The Ayushman Bharat Digital Mission is designed to create interoperable digital health infrastructure, and by May 2026 the government was talking about more than 100 crore health records linked with ABHA. For a startup like Hoola, that digital backbone makes continuity of care a lot more realistic than it was a few years ago.

Public spending priorities help too. India’s 2026-27 health budget raised National Health Mission allocation to ₹39,390 crore, with the ministry explicitly highlighting maternal and child health and primary healthcare delivery. NHM planning documents for 2026-27 still keep child health and immunisation inside the core deliverables. That doesn’t automatically hand startups a win, but it does mean Hoola is building into a system where prevention, immunisation, and longitudinal records are getting more policy attention, not less.

Investor interest across Indian healthcare also hasn’t gone away. At the bigger end of the market, Manipal Health filed for an up to $1.17 billion IPO in March 2026. That’s not directly comparable to a paediatric clinic startup. But it does show capital still likes scaled healthcare assets when the model looks durable.

What to watch after Hoola Health funding

Hoola Health funding gives the company enough capital to try something bigger than a nice local clinic brand. It can now test whether a child-first, integrated paediatric care model travels across cities without losing the trust that seems to be driving its early growth.

The next thing to watch is simple: can Hoola open new centres fast enough and keep repeat behaviour high? Can it make its digital layer genuinely useful instead of decorative? If it can, this won’t just be another clinic expansion story. It could become one of the more interesting primary-care builds in Indian healthcare.

Read how Exponent Energy raised ₹200 crore in funding to expand its rapid-charging platform for commercial EVs, combining batteries, chargers, and energy management into a full-stack system designed to keep fleet vehicles on the road with minimal downtime.

FAQ

• What is the Hoola Health funding round? Hoola Health raised $5 million in June 2026. Peak XV’s Surge led the round, with existing investor W Health Ventures and angel investors Ashish Gupta, Abhishek Goyal, and Bijou Kurien also participating.
• How does Hoola Health work for parents? It works as a blended paediatric care model built around neighbourhood clinics plus digital support. Parents can use it for consultations and vaccinations. They can also use it for developmental checks, therapy, and follow-ups, while the company keeps records for things like growth tracking, prescriptions, and immunisation history.
• Who founded Hoola Health? The company was founded in Bengaluru in 2024 by Deeksha Senguttuvan. Before starting BabyMD, which later rebranded to Hoola Health, she worked in healthcare and technology, including a digital transformation role at Kauvery Hospital, and studied at Wharton, IIM Kozhikode, and NIT Tiruchirappalli.
• Is Hoola Health a hospital company or a healthtech startup? It’s closer to a paediatric primary-care and clinic startup with a digital layer than to a hospital operator. The company’s model is built around recurring family care — everyday consults, vaccinations, developmental services, and records — rather than high-acuity inpatient care.

Exponent Energy builds rapid-charging systems for commercial electric vehicles, and it has now raised ₹200 crore ($21.1 million) to scale that model. The pitch is straightforward: fleet operators don’t have hours to spare when a vehicle needs power, even if EV economics look attractive on paper. Founded in 2020 in Bengaluru by Arun Vinayak and Sanjay Byalal Jagannath, Exponent Energy will use the new capital to enter more cities, add vehicle categories, and keep developing its charging tech.

What is Exponent Energy and how does it work?

Exponent Energy sells a tightly integrated charging stack for commercial EVs — not just a charger, and not just a battery. Its system combines the battery pack inside the vehicle and the charger at the station. The connector links the two. On top of that, Exponent ONE handles financing and asset management, so OEMs and fleet operators can source vehicles, power them, and manage the energy layer through one setup instead of stitching together vendors on their own.

The technical bit matters here. Exponent had to redesign every part of the charging system to get to a 15-minute full charge while still using regular LFP cells. The stack includes a battery management system and a virtual cell model. It also uses a dynamic charging algorithm, plus offboard thermal management. That’s the company’s core claim: fast charging without wrecking battery life the way conventional rapid-charging approaches often do.

It also isn’t trying to lock drivers into a closed loop forever. Exponent offers a 3,000-cycle warranty, and its vehicles can use Exponent stations, public chargers, and home charging points. That interoperability matters more than the headline charge time. Commercial operators care about uptime and fallback options just as much as peak speed.

The company is stretching the same logic across formats. Its platform already covers autorickshaws and cargo three-wheelers. It offers retrofit options for some CNG and LPG autos, and it has started talking up 1.5 MW charging for buses. That broadens the story from “nice charging trick” to “serious commercial vehicle infrastructure bet.”

Who founded Exponent Energy and what has it built?

From Ather to a charging company

Arun Vinayak and Sanjay Byalal Jagannath started Exponent Energy after both left Ather Energy. Vinayak had been a founding partner and chief product officer at Ather, which gives him credibility in EV product development. Jagannath brought operating experience too, with time at Ather and earlier work in supply chain and operations at HUL. That combination — product plus operations — fits the kind of hardware-heavy business Exponent is trying to build.

They launched Exponent in 2020 with a different angle from most EV startups. Instead of becoming another vehicle maker, they went after the energy bottleneck around commercial fleets. It makes sense. In India, the vehicle isn’t the whole problem. The refueling experience is.

The rollout is no longer theoretical

This isn’t still in lab-demo mode. Exponent began commercial operations in March 2023, and its own network now spans 4 cities with 162+ charging stations. More than 2,000 vehicles are already on the road using its tech, with 3,15,000+ charging sessions completed and over 90,00,000 km logged. Those aren’t giant numbers yet, but they show the model has moved beyond pilots.

The early OEM ties help. Exponent has worked with Altigreen and Montra Electric on cargo three-wheelers. It later expanded with Omega Seiki Mobility into passenger three-wheelers. That matters because Exponent isn’t trying to win consumers one charging session at a time. It’s trying to be embedded in the vehicle programs themselves.

The funding stack — and who it’s up against

The new ₹200 crore round was co-led by 360 ONE Asset and TDK Ventures. Hitachi Ventures also joined. Existing investors Eight Roads Ventures, Lightspeed, 3one4 Capital, AdvantEdge VC, and YourNest came back in. YourNest, which backed Exponent early, added another $4 million through its Continuum Fund. That pushes total funding since 2020 to $65.7 million. Exponent had previously raised $26.4 million in a Series B round led by Eight Roads Ventures in December 2023.

The investor mix says a lot. This was 360 ONE Asset’s first investment in the EV sector, and Hitachi Ventures’ first energy-sector investment in India. TDK Ventures, already on the cap table, made a follow-on investment. That’s not tourist capital. Investors think Exponent has built something hard enough to defend.

Competition is real, though. SUN Mobility attacks the same downtime problem through battery swapping and has 630+ active swap stations in India. ChargeZone comes from the public-network side, with 13,500+ charging points across 26 states. The old-school alternative is slower depot charging, which is cheaper to start with but often painful for high-utilisation fleets. Exponent’s edge is that it isn’t a pure public charging network, and it isn’t a swapping player either. It’s a closed-loop battery, charger, and OEM integration model aimed squarely at commercial usage.

Why does Exponent Energy’s new round matter?

Because this is the ugly part of the business.

Proving a 15-minute charge in a handful of deployments is hard. Scaling that across cities, vehicle formats, service teams, hardware reliability, and financing products is much harder. Exponent will use the money for city expansion, new vehicle categories, and more R&D. That’s exactly where a company like this needs capital once the first wave of pilots is over.

For customers, the round should mean broader coverage and a more usable network. That’s the real test. Fast charging only changes commercial fleet economics when it’s available where the vehicles actually run — depots, urban corridors, and eventually highways. The company is also building more around Exponent ONE, so the pitch isn’t just “charge faster.” It’s “buy, finance, charge, and manage the vehicle through one operator.”

The investor pitch is blunt, and useful. Sumit Jain of 360 ONE Asset said, “Exponent is solving the hard problems in commercial EV adoption – balance between cost, practicality and ability for operators to access the incredible TCO advantage offered by the EV paradigm — all through its full-stack ultra fast-charging platform that spans both battery and a purpose-built charging ecosystem.” Arun Vinayak put it more clearly: the round comes at a defining moment, and Exponent 2.0 is meant to build a “category defining energy company” for electric mobility.

How big is India’s EV charging market getting?

India’s charging buildout is still early, but the direction is obvious. The IEA expects the country’s public charging points to rise from 75,000 at the end of 2024 to around 375,000 by the end of 2030. To get there, India would need to add roughly 50,000 public charging points a year through 2030. The same outlook ties that expansion to support for a stock of under 3 million electric light-duty vehicles, while PM E-DRIVE includes ₹20 billion for public charging stations and support for 22,100 chargers for electric four-wheelers through March 2026.

The commercial side is why Exponent is interesting. In an earlier funding round, Eight Roads said commercial vehicles make up roughly 10% of vehicles but account for about 70% of on-road energy use. That’s why fleet charging keeps pulling serious capital. India is also pushing electric buses through the PM eBus Sewa scheme, which targets 10,000 buses under a PPP model, while the Ministry of Power’s 2024 charging guidelines put more weight on connected and interoperable infrastructure, including battery swapping.

Money is moving across the whole stack, not just into vehicle brands. Ola Electric recently raised about ₹780 crore through a qualified institutional placement. IFC also backed GFCL EV with about $50 million for a battery materials facility in Gujarat. That points to the next bottlenecks: charging networks, battery inputs, and the infrastructure layers that decide whether EV adoption actually scales.

What to watch next for Exponent Energy

Exponent Energy has enough proof now to be taken seriously, but not enough scale to relax.

This round gets interesting here. If the company can turn its integrated charging stack into a denser city network and win more OEM programs, it could become a real piece of India’s commercial EV backbone. If not, it risks becoming another clever hardware startup that worked in pockets and stalled in expansion. For Exponent Energy, the next 12 to 18 months are about one thing: whether fast charging can become routine, not remarkable.

Read how Uni Seoul raised ₹35 crore in a Series A round co-led by Riverwalk Holdings and Sauce.vc to scale its Korean-inspired lifestyle retail brand, combining affordable gifting products, immersive stores, and an offline-first growth strategy across India.

FAQ

• What funding did Exponent Energy raise? Exponent Energy raised ₹200 crore, or about $21.1 million, in June 2026. The round was co-led by 360 ONE Asset and TDK Ventures, with Hitachi Ventures joining and existing backers like Lightspeed, Eight Roads Ventures, 3one4 Capital, AdvantEdge VC, and YourNest participating again.
• How does Exponent Energy charging work? Exponent Energy uses a full-stack setup that links the battery pack, charger, connector, and software controls into one system. Its stack includes a battery management system and virtual cell model. It also uses a dynamic charging algorithm, plus offboard thermal management, which enables a 15-minute full charge while still using regular LFP cells.
• Who founded Exponent Energy? Exponent Energy was founded in 2020 by Arun Vinayak and Sanjay Byalal Jagannath in Bengaluru. Vinayak previously helped build Ather Energy as a founding partner and chief product officer, while Jagannath brought experience from Ather and earlier supply-chain and operations work.
• What market is Exponent Energy in? Exponent Energy sits in the commercial EV charging and energy infrastructure market, with a focus on fleets rather than casual consumer charging. It competes against slower depot charging, public-network operators like ChargeZone, and battery-swapping players such as SUN Mobility, but its bet is that integrated plug-in fast charging can work better for many commercial operators.

Uni Seoul is a Pune-based D2C brand that sells Korean-inspired lifestyle and gifting products through an offline-first retail model. Its new Uni Seoul funding round brings in ₹35 crore, or about $3.6 million, in a Series A co-led by Riverwalk Holdings and Sauce.vc, with Panthera Peak Ventures and existing angel investors also joining in. It’s chasing a simple gap: India has lots of gifting and impulse-buy retail, but not many chains that package Korean-inspired design and affordable pricing under one brand. Founded in 2023 by Gaurav Karmani and Mohit Khurana, the startup now wants to turn that gap into a national roll-up story.

What is Uni Seoul and how does it work?

Uni Seoul is a design-led retail brand built around low-ticket, high-appeal products people buy for themselves or as gifts. Its catalogue spans more than 1,000 SKUs across plush toys, home décor, stationery, bags, travel accessories, beauty products, and other gifting items, with pricing from ₹99 to ₹2,999. Online, the brand mixes a standard storefront with shoppable short-video merchandising. Offline, it uses stores as the main discovery engine.

The customer flow is clear. You walk into a store in a premium mall or high street, browse tightly merchandised displays, pick up an impulse item like a plushie keyring, perfume, bento box, scrunchie, tumbler, or neck pillow, and check out at a price point that doesn’t need much deliberation. If you’re online, the same logic shows up through curated collections and “watch and shop” content rather than endless marketplace-style scrolling.

That sounds small. It isn’t. Uni Seoul is trying to remove the usual friction in aesthetic retail — scattered sellers, uneven quality, and no coherent brand feel — by curating the full experience itself. Its design philosophy is blunt: take everyday-use items, add Korean-inspired styling, keep them functional, and make them affordable enough to turn browsing into buying.

The stores matter more than the website here. Mohit Khurana has said the concept was built for physical retail because customers need to experience the “cuteness” aesthetic in person. That also explains the heavy emphasis on visual merchandising and extras like photobooth-style moments that turn the shop into a social visit, not just a transaction.

Who built Uni Seoul and what makes the company credible?

The founding story

Uni Seoul was started in 2023 in Pune by childhood friends Mohit Khurana and Gaurav Karmani. The spark came from Khurana’s exposure to Asian variety retail during his travels, especially brands like Miniso, Daiso, and Artbox, which turned ordinary household and gifting products into fun, design-first purchases. His read was that India still lacked a scaled version of that format with a stronger Korean aesthetic and more accessible pricing.

That origin story matters because Uni Seoul doesn’t look like a random trend chase. It’s a deliberate retail thesis: take the emotional pull of K-culture, strip away the imported-premium pricing, and rebuild the model for Indian malls and high streets. Franchise-led expansion comes later.

Founder-market fit

Khurana’s background is unusually operator-heavy for a lifestyle brand founder. He began his entrepreneurial career in 2008 with a learning and development company. He later held leadership roles across WhiteHat Jr, Vedantu, Lentra, BYJU’S, and Narayana Group, and also founded Incisive Training. That kind of resume doesn’t scream plush toys and stationery on paper, but it does point to sales discipline, store economics awareness, and scale habits.

Karmani brings the piece that retail brands can’t fake for long — on-ground merchandising and expansion instinct. He has more than a decade in retail, and that lines up with Uni Seoul’s bias toward physical stores, premium locations, and experience-led execution. If Khurana is the growth-and-operations side, Karmani is much closer to brand buildout and store rollout.

Execution so far

For a startup founded in 2023, the early rollout has been fast. Uni Seoul now operates 15 stores across Bengaluru, Pune, Mumbai, Hyderabad, Ahmedabad, and Nashik. In an earlier interview, Khurana said the Church Street flagship in Bengaluru was clocking trading densities of around ₹4,000 per sq. ft. That’s a useful signal.

The company’s format mix is also getting sharper. It has talked publicly about combining company-owned and franchise-led models. Its five-year target is 500 retail touchpoints — aggressive, yes, but at least tied to a specific operating structure rather than vague omnichannel talk.

Fundraising details

This Series A brings in ₹35 crore and was co-led by Riverwalk Holdings and Sauce.vc, with Panthera Peak Ventures and existing angel investors participating. The money is earmarked for offline expansion across premium malls and high streets in Tier I cities. It also covers entry into quick-commerce platforms and stronger supply-chain plus private-label capabilities. Before this, Uni Seoul had raised ₹5 crore in seed funding on April 22, 2025, in a round led by Sauce VC.

Karmani’s own explanation is more useful than the usual founder boilerplate: the brand wants more SKUs, tighter visual-merchandising standards across stores, and a product experience that feels the same whether a customer walks into Bengaluru or finds the brand online. The job of this round is standardization, not just expansion.

Competition and positioning

Uni Seoul isn’t entering an empty market. Khurana has directly cited Miniso, Daiso, and Artbox as inspiration, and Indian shoppers already know the broad category through value lifestyle chains like Miniso and Mumuso, plus Korean-inspired digital players like Myoto. Those rivals have already trained the customer to browse for affordable, design-forward, Asian-aesthetic products.

Uni Seoul is trying to draw a line in positioning. It leans harder into Korean-inspired gifting, beauty, plush, décor, and stationery under one house brand, while also pitching itself as “Korean-inspired, Indian-made.” That matters because it gives the company a shot at better control over sourcing and margins. It also helps with localization and replenishment. Investors are betting that this mix — affordable design, offline discovery, private label, and quick-commerce adjacency — can build a defensible consumer brand instead of just another novelty store chain.

What does Uni Seoul funding change now?

The immediate change is pace. Uni Seoul wants to go from 15 stores to more than 50 in the near term, and that kind of jump breaks weak retail systems fast. More capital lets it secure better locations and carry deeper inventory. It also helps tighten execution standards across stores before inconsistency creeps in.

The more interesting shift is channel expansion. Uni Seoul is preparing to launch on Blinkit, Zepto, and Swiggy Instamart, which makes a lot of sense for gifting items and low-consideration beauty or accessory purchases. If the brand can translate store-led discovery into quick-commerce replenishment and impulse buys, it stops being just a mall brand. It starts acting more like an always-available retail layer.

There’s also a private-label angle here. When a retail startup says it wants to strengthen supply chain and private label, that usually means one thing: better gross margins and tighter control over what actually lands on shelves. For Uni Seoul, that could be the difference between a cute concept and a real chain.

Why is Uni Seoul funding landing at the right time?

Part of the answer is cultural. K-pop, K-dramas, and K-beauty have moved well beyond niche fandom in India, and Uni Seoul is using that spillover effect across categories, not just skincare. The company’s source article pegs India’s K-beauty market at $1.5 billion by 2030, with a 25.9% CAGR. This isn’t just a meme trend anymore.

Part of it is retail infrastructure. JLL says India recorded 3.1 million sq. ft. of retail leasing in Q1 2026, with about 46.1 million sq. ft. of new supply expected by 2030. D2C brands accounted for 7% of leasing activity in the quarter, and high streets captured 48% of transactions as brands kept chasing physical visibility even when mall supply stayed tight. That’s almost a perfect backdrop for a brand obsessed with premium malls and busy high streets.

Quick commerce is turning into a real distribution muscle, not a side experiment. Redseer expects quick commerce to account for 10% of all branded retail sales by 2030, up from 1% in 2024, with beauty and personal care particularly well placed on the channel. Uni Seoul isn’t a pure beauty company, but it sells the kind of small-ticket, fast-grab products that fit dark-store economics and impulse behavior.

So yes, this round is about one brand. It also says something bigger: investors still believe digitally native consumer brands can win offline in India — if they give shoppers a reason to leave the app and walk into the store first.

Conclusion

The smartest read on Uni Seoul funding is that investors aren’t just backing Korean-inspired gifting. They’re backing a retail format. Uni Seoul now has to prove that its mix of visual merchandising, private label, premium locations, and quick-commerce access can scale without losing the charm that got customers in the door in the first place. The test is simple: whether 50 stores still feel like one brand.

Read how HyperNorm AI raised $2.2M in seed funding to help wealth advisors make faster portfolio decisions through an AI-powered intelligence platform that connects market events, client portfolios, and actionable recommendations in real time.

Uni Seoul funding FAQ

• What is the latest Uni Seoul funding round? Uni Seoul has raised ₹35 crore in a Series A round co-led by Riverwalk Holdings and Sauce.vc. Panthera Peak Ventures and existing angel investors also participated, and the company had previously raised a ₹5 crore seed round on April 22, 2025.
• How does Uni Seoul work as a retail brand? Uni Seoul runs an offline-first lifestyle and gifting model built around Korean-inspired design. Customers shop through physical stores and an online storefront that includes shoppable video merchandising. Products span categories like décor, plush, stationery, travel accessories, and beauty.
• Who founded Uni Seoul? Uni Seoul was founded in 2023 by Mohit Khurana and Gaurav Karmani. Khurana came in with experience across entrepreneurship, edtech, and SaaS operating roles, while Karmani brought more than 10 years of retail experience — a useful mix for a brand trying to scale stores fast.
• Is Uni Seoul a K-beauty brand or a broader lifestyle company? It’s broader than K-beauty. Beauty is one part of the mix, but the company sells more than 1,000 SKUs across gifting and lifestyle categories, with price points running from ₹99 to ₹2,999 and a strong emphasis on everyday impulse purchases.

HyperNorm AI builds decision intelligence software for registered investment advisors and wealth managers. The HyperNorm AI funding round brings in $2.2 Mn, or about ₹19.5 Cr, as the startup tries to turn that idea into a bigger US business. The pitch is pretty clear: advisors don’t need more raw market data. They need faster judgment on what matters right now. Founded in 2024 by Keyur Faldu and Peeyush Jain, the company is betting that explainable AI for portfolio decisions is finally becoming something firms will pay for.

What is HyperNorm AI and how does it work?

Here’s the simple version.

HyperNorm AI watches market events, links them to actual client portfolios, and tells an advisor which accounts need attention first. Instead of dumping charts and alerts into another dashboard, it ranks portfolios by urgency and risk exposure. Client mandate is part of that. Then it explains what changed, why it matters, and what action may fit the account.

That workflow is where the product gets more interesting. The system maps macro shifts, earnings events, sentiment moves, and other signals to a firm’s book in real time. It doesn’t stop at surfacing the event. It pushes toward a recommendation layer, filtered through risk profile, goals, and mandate, and gives advisors scenario analysis before they act.

There’s also a practice-management angle baked in. HyperNorm includes meeting intelligence that turns client conversations into tasks and follow-ups. Possible portfolio actions are part of that. It also offers goal monitoring and AI research assistants for themes and stocks. Market-and-macro signal tracking is in there too. In plain English, it’s trying to compress the work between “something happened” and “here’s what I should tell this client.”

Before a tool like this, an advisor might bounce between portfolio software, notes, research terminals, emails, and CRM records just to decide who needs a call. HyperNorm is selling the opposite experience: one decision layer sitting on top of that mess. The startup puts a few bold numbers on its own product pages — 70M+ events analysed in near real time, 65% directional accuracy on stock and fund price predictions, and 4x advisor capacity without adding headcount. The harder test is whether RIAs keep expanding usage after the first pilot.

Who founded HyperNorm AI and what traction does it have?

This didn’t come out of nowhere.

How HyperNorm AI started

HyperNorm AI was founded in 2024 by Keyur Faldu, the CEO, and Peeyush Jain, the CTO. They built it around a very specific problem inside wealth management: firms already have tons of information, but they still struggle to convert noise into timely, defensible action for each client.

Faldu summed that up in the source article: “Modern wealth management does not suffer from a lack of information. It suffers from a lack of clarity on what matters now and what action should be taken.”

That’s a sharp framing.

Why the founders fit this market

Faldu’s background leans hard into AI and research. He has worked at Meta, McKinsey, and Embibe, studied computer science at IISc Bangalore, and has been involved in explainable AI and knowledge-graph research. That matters because HyperNorm’s whole sales story rests on causal reasoning and explainability, not just flashy large-language-model output.

Jain brings the product-and-systems side. Before HyperNorm, he worked at Verloop, Embibe, and BT, and studied computer science at IIT Kanpur. His track record is in building and scaling software products and engineering teams. That’s exactly what a startup needs when it’s trying to move from an early product into a repeatable SaaS business.

Put those two profiles together and the founder-market fit is solid. One side understands AI systems deeply. The other knows how to ship and scale software.

Is the product live, and is anyone paying?

Yes. And that’s one of the more important details in this round.

HyperNorm rolled out a beta version to advisors, portfolio managers, and CIOs in late 2025, and early revenue started coming in during that phase. It now serves paying customers across the US, Singapore, and India. That doesn’t tell us customer count or revenue size, but it does tell us this isn’t a pure concept-stage company.

The business model is recurring. HyperNorm charges a mix of per-seat licensing and usage-based pricing. That’s a logical setup for advisor software. If a firm adds more advisors, covers more portfolios, or routes more workflows through the system, the revenue base should expand with it.

Who backed the round, and who is HyperNorm really up against?

The seed round brought in $2.2 Mn from Capital 2B, SenseAI Ventures, Boundless Ventures, iOPEX Technologies, and angel investors including Amit Sheth and Bhavin Manek. HyperNorm will use the money for product development, US and international expansion, and bigger engineering and AI research teams.

Competition is real. Nevis is pushing an AI platform for wealth management with a heavy focus on workflow automation and client-service tasks. Advisor operations end to end are part of that. Altruist comes from a different angle — more custodian and infrastructure stack than pure decision engine — with account opening, trading, billing, reporting, and portfolio management in one platform.

That gives HyperNorm a distinct lane, at least for now. It’s less about becoming the entire operating system for an RIA and more about becoming the intelligence layer that tells the advisor what deserves action and why. The legacy alternative is even messier: separate portfolio tools, custodial systems, CRMs, research products, analyst notes, and a lot of human synthesis in spreadsheets and inboxes. If HyperNorm wins, it’ll be because it cuts through that fragmentation without asking firms to rip out everything they already use.

What does HyperNorm AI funding change now?

It’s only $2.2 million. That’s not huge by fintech standards.

But for this kind of company, the amount makes sense. HyperNorm isn’t building a consumer finance app that needs massive marketing spend. It’s building enterprise-style software for advisors, where sharper product execution and trust matter more than flashy growth headlines. A seed round this size can fund a serious engineering push, especially if the founders are disciplined about scope.

Timing matters too. HyperNorm already has paying users in 3 markets, so the money isn’t just financing an idea deck. It’s meant to help the company deepen the product and sell more aggressively in the US, where RIAs are a large, fragmented, software-buying customer base.

There’s a quiet signal in the investor mix too. You’ve got venture firms, a strategic corporate backer in iOPEX Technologies, and angels with AI credibility. That suggests investors aren’t only buying the wealthtech narrative. They’re buying the view that explainable, decision-first AI could become core infrastructure for advisory work.

Why are investors chasing wealth management AI?

Wealthtech isn’t short on vendors. What changed is the urgency.

The global wealth management software market was valued at $6.3 billion in 2025, is estimated at $7.2 billion in 2026, and is projected to reach $18.8 billion by 2033. That kind of growth doesn’t happen because firms suddenly love buying software. It happens because the job itself is getting harder. Advisors are managing more complex portfolios across equities, fixed income, structured products, and other asset classes, while clients expect faster answers and more personalization.

AI adoption is already moving well past curiosity. In one 2026 industry survey, 89% of wealth management respondents said they use AI and data analytics to support decision-making. Nearly half said they use real-time insights for automated decision-making and business strategy, while 40% reported using predictive models and dashboards. That doesn’t mean every firm is AI-native. It does mean the budget conversation has already started.

You can see the money following that trend. In November 2025, wealthtech startup Wealthy raised ₹130 crore to build out AI-powered tools and digital infrastructure for mutual fund distributors. HyperNorm is smaller and earlier, but it’s riding the same broad shift: more advisory workflows are being rebuilt around AI, and investors don’t want to miss that cycle.

What should you watch after HyperNorm AI funding?

Seed rounds are cheap talk. Distribution isn’t.

HyperNorm AI funding gives the startup time to hire, refine the product, and push harder into the US. What matters next is whether it can turn early paid usage into durable RIA adoption, especially in firms that already have crowded software stacks and little patience for another tool. If the startup starts winning deeper workflow ownership instead of narrow pilot budgets, this gets more interesting.

Read how Sandstone raised a $30M Series A led by Lightspeed Venture Partners to help in-house legal teams manage requests, workflows, drafting, and reviews through an AI-powered operating system built for corporate legal departments.

FAQ

• What funding did HyperNorm AI raise? HyperNorm AI raised $2.2 Mn in seed funding, which is about ₹19.5 Cr. The round included Capital 2B, SenseAI Ventures, Boundless Ventures, iOPEX Technologies, and angel investors such as Amit Sheth and Bhavin Manek. The company plans to use the money for product work, market expansion, and team building.
• How does HyperNorm AI work for RIAs and wealth advisors? HyperNorm AI works as a decision intelligence layer for advisors. It tracks market events, connects those signals to specific client portfolios, and recommends actions that fit each client’s mandate and risk profile. Goals are part of that too. It also handles meeting follow-ups and research queries. Goal tracking is included as well. That means it’s trying to shrink both portfolio analysis work and advisor admin.
• Who are the founders of HyperNorm AI? HyperNorm AI was founded in 2024 by Keyur Faldu and Peeyush Jain. Faldu is the CEO and has worked across AI, data, and research roles at Meta, McKinsey, and Embibe, while Jain is the CTO and has held product and engineering roles at Verloop, Embibe, and BT. Their backgrounds line up closely with what HyperNorm is trying to sell: explainable AI software for financial decision-making.
• Is HyperNorm AI a wealthtech startup or an enterprise AI startup? It’s really both, but wealthtech is the cleaner label. HyperNorm sells software into wealth management firms, specifically RIAs and advisors, so its immediate market is advisor infrastructure and portfolio intelligence. At the same time, the core product is built around enterprise AI, causal reasoning, and explainability. That’s why the company sits in that overlap between fintech software and applied AI.

Sandstone builds in-house legal AI software that turns scattered requests from Slack, email, and ticketing tools into structured workflows for corporate legal teams. The Brooklyn startup has raised a $30 million Series A led by Lightspeed Venture Partners, just 6 months after a $10 million seed round led by Sequoia in January 2026. The pitch is simple: in-house lawyers are buried under operational work that arrives through too many systems at once, and most legal AI products still aim at law firms instead. Sandstone was founded in 2025 by Nick Fleisher, Jarryd Strydom, and Liam Germain to go after that gap.

That matters because legal AI is getting crowded fast. Harvey and Legora have soaked up giant funding rounds by selling AI tools for private practice, while Anthropic has spent 2026 pushing Claude deeper into legal workflows. Sandstone is taking a different route. It wants to become the operating layer for in-house teams at small and midsized businesses, where the pain is less about courtroom reasoning and more about intake, routing, drafting, review, and keeping the whole department from turning into one giant shared inbox.

What is Sandstone and how does its in-house legal AI work?

Sandstone is an in-house legal AI platform built around intake and workflow execution. A request comes in through Slack, Gmail, Outlook, Jira, or another business system. Sandstone’s agent reads the request and asks follow-up questions if key facts are missing. Then it classifies the matter and routes it to the right person, template, or workflow. Instead of making legal teams force the company onto a new portal, it plugs into the tools people already use.

That’s the product distinction. Sandstone isn’t trying to be a chat window that spits out legal answers in isolation. It aggregates the business context around a request — prior agreements, playbooks, workflow history, and system data. Then it surfaces that context before a lawyer starts work. The platform also includes reporting so legal leaders can see what kinds of requests are coming in, where work is slowing down, and which processes are becoming repeatable.

The workflow looks a lot more operational than glamorous. A salesperson drops a note into a legal Slack channel. Sandstone figures out whether it’s an NDA, a DPA, a vendor review, or something else. It gathers missing details, checks against encoded playbooks, and proposes the next path — self-service, template output, or assignment to counsel. That removes the manual work that chews up a legal team’s day before the actual legal judgment starts.

It’s also being built as a system product, not a single feature. Sandstone supports more than 50 instant integrations, plus agentic workflows that move matters from intake to execution. That means drafting and first-pass review can sit on top of the same intake layer. So can routine redlining and legal analysis.

Who founded Sandstone and why are the founders credible?

The founding story

Sandstone came out of a very specific view of where legal software breaks. CEO Nick Fleisher spent years at McKinsey leading legal technology work, advising law firms and in-house teams on operations, data, AI, and talent. He saw the same pattern again and again: more work was moving in-house, but the lawyers hired to handle strategy and risk were still stuck triaging requests and hunting for context across fragmented systems.

Strydom had lived the same mess from the inside. Before Sandstone, he worked as in-house counsel at a fast-growing B2B software company and also practiced in private firms. That gave him a more grounded read on the day-to-day work than you usually get from a pure software founder. Germain rounded out the founding trio on the technical side. He’s listed as Sandstone’s CTO and helped build the company alongside Fleisher and Strydom in 2025.

One detail stands out: Fleisher and Germain were first-year roommates at Penn before they became co-founders. It doesn’t make the product better on its own, obviously. But for investors, long-standing founder relationships still matter when a company is trying to move this fast.

Why these founders fit the problem

Founder-market fit is strong here. Fleisher knows legal tech buying behavior and enterprise process pain from the advisory side. Strydom knows what legal departments actually deal with when requests come in through every possible channel. Sandstone’s broader team includes former Big Law lawyers, legal engineers, and operators with backgrounds tied to companies like Microsoft, Google, Amazon, NetDocuments, Robin, Akin Gump, Paul Hastings, and Davis Polk. That’s unusually dense domain experience for a company this young.

Fundraising and early signals

The new round is big by any standard for a startup founded in 2025. Sandstone announced its $30 million Series A on Tuesday, June 9, 2026. Lightspeed Venture Partners led the round. Existing backers Mantis VC, SV Angel, Operator Partners, Kearny Jackson, Daybreak Ventures, Litquidity Ventures, and others joined in. This followed a $10 million seed round in January 2026 led by Sequoia.

That’s $40 million raised within roughly 6 months of its seed launch. Sandstone hasn’t publicly shared customer counts or revenue, but it has been explicit about its first target market: in-house legal departments at small and midsized businesses. In a market full of broad AI claims, that narrow starting point is a good sign.

How Sandstone compares with Harvey, Ironclad, and the old way

This is where Sandstone gets interesting. Harvey and Legora are the obvious headline names in legal AI, but they’ve built momentum around law firms and research-heavy workflows. Sandstone isn’t chasing that same buyer or workflow. It’s closer to the operational layer for in-house teams — the stuff between a business request showing up and legal work getting resolved.

Its more direct competition comes from legal intake and workflow products aimed at corporate legal departments, including Coheso, Checkbox, Argos, Dazychain, and Streamline AI. Those products all promise some version of a legal front door: centralized intake, triage, routing, and visibility. Then there are bigger adjacent incumbents like Ironclad, which owns more of the contract lifecycle management side for in-house teams.

Sandstone’s differentiation is that it’s pitching a context-rich workflow layer rather than just intake forms or contract tooling. Strydom’s own explanation gets at that: AI only helps if it understands the actual workflow in detail. That’s also the investor bet. Lightspeed isn’t just backing “legal AI.” It’s backing specialized vertical software for a part of the legal stack that still feels underbuilt.

Why does this in-house legal AI funding matter?

Because this round says something about what investors think the next wave of legal software will look like.

The first wave of legal AI money went hard at law firms, research, and drafting. Fair enough. That’s where the headlines were, and that’s where massive budgets already existed. But Sandstone’s Series A suggests investors also see a big opening inside corporate legal departments, especially teams that don’t have giant ops budgets or patience for long implementation cycles.

It also matters because Sandstone raised the round absurdly fast. A seed in January 2026. A $30 million Series A in June 2026. That kind of velocity usually means one of two things: either the market is overheating, or the company is showing investors a product and customer response that feels unusually sharp. Sometimes it’s both.

For customers, the implication is practical. If Sandstone executes, small and midsized legal teams could get a system that behaves less like another dashboard and more like an extra operator sitting between the business and legal. That won’t replace counsel. But it could cut a lot of the routing, summarizing, and repeat drafting that makes in-house work drag.

How big is the in-house legal AI market?

Big enough that a focused startup can build a serious company without winning the whole legal industry.

Grand View Research estimates the global legal AI market was worth $1.45 billion in 2024 and could reach $3.90 billion by 2030, a 17.3% annual growth rate. Its broader legal technology estimate is even larger: $28.7 billion in 2025, growing to $69.7 billion by 2033. In the U.S. alone, legal technology spending was estimated at $7.3 billion in 2024, with corporate legal departments counted as a meaningful end-use segment.

The adoption curve is moving fast too. Anthropic’s 2026 legal guide cites an FTI Consulting and Relativity general counsel report showing 87% of general counsel now report genAI use inside their teams, up from 44% the year before. The same guide says summarization, contract clause identification, and transcription are already among the top in-house legal use cases. That lines up almost perfectly with where Sandstone is starting.

The spending pressure is real. Thomson Reuters says average law firm spending on technology grew 9.7% in 2025, while spending on knowledge management tools rose 10.5%. It also found firms with a visible AI strategy were 3.9 times more likely to report at least one form of ROI. That’s law-firm data, sure, but the client pressure behind it is coming from corporate legal buyers who want more work handled faster and cheaper.

Sandstone still has a lot to prove. Legal departments are cautious buyers. Workflow software can get messy fast. Frontier model companies are creeping deeper into the same budget lines. But the startup’s bet on in-house legal AI feels sharper than a lot of “AI for lawyers” pitches because it starts with the boring work that actually eats the day.

Read how BazaarNow raised ₹72 crore led by Peak XV Partners to build a vernacular-first quick commerce platform tailored for tier-2 and tier-3 India, combining local-language search, assisted ordering, and in-house logistics.

FAQ

• What funding did Sandstone raise? Sandstone raised a $30 million Series A announced on June 9, 2026. Lightspeed Venture Partners led the round, and it came only 6 months after a $10 million seed round in January 2026 led by Sequoia. That makes the company’s fundraising pace unusually fast even by legal tech standards.
• How does Sandstone’s product work for in-house legal teams? Sandstone works like an AI intake and workflow layer for legal departments. It pulls requests from tools like Slack, Outlook, Gmail, and Jira. It asks for missing context, classifies the matter, routes it to the right owner or playbook, and helps with tasks like drafting, review, redlining, and reporting inside one connected system.
• Who founded Sandstone? Sandstone was founded in 2025 by Nick Fleisher, Jarryd Strydom, and Liam Germain. Fleisher previously led legal technology work at McKinsey. Strydom had worked as in-house counsel and in private practice, and Germain serves as CTO — a mix that gives the company both legal-ops insight and product-building depth.
• What market is Sandstone targeting? Sandstone is selling into the in-house legal AI and legal workflow automation market, with an initial focus on small and midsized business legal departments. That niche sits inside a broader legal tech market that Grand View Research estimates at $28.7 billion globally in 2025, while adoption of genAI inside legal departments has already jumped sharply in 2026.

BazaarNow is a quick commerce startup that delivers groceries, fruits, vegetables, and daily essentials with a model built for India’s smaller cities. The Bengaluru-headquartered company has raised ₹72 crore led by Peak XV Partners, a BazaarNow funding round that matters because tier-2 and tier-3 grocery buying still doesn’t behave like metro quick commerce. Founded in January 2026 by former Zepto executives Priyanshu Jain, Arjun Harish, and Tarithmay Mandal, the startup is trying to solve a specific gap: people outside the big metros want convenience, but not the coupon-heavy, app-first playbook that dominates urban quick commerce.

What is BazaarNow and how does it work?

BazaarNow is basically a vernacular-first grocery app for tier-2 and tier-3 India. A customer opens the app and searches in a local language. Then they place an order for staples or fresh produce, and BazaarNow routes it through its own logistics stack for fulfillment. The company also supports assisted shopping, including call-to-order. That matters in markets where digital comfort levels vary a lot from one household to the next.

That product design shows what the founders think the real bottleneck is. It’s not just delivery speed. It’s discovery and trust. It’s also ease of ordering for people who may not want to type brand names in English or hunt through layers of cashback offers. BazaarNow’s AI-powered local-language search is built around that behavior. It isn’t copying a metro user journey and hoping it transfers.

BazaarNow also runs an in-house rider management and logistics system. That gives it tighter control over fulfilment in markets where address mapping, rider availability, and fresh inventory turnover can get messy fast. It’s a practical choice. In smaller cities, quick commerce breaks when the back end isn’t tuned to local conditions.

Who founded BazaarNow and why are investors betting now?

Founded by three former Zepto operators

BazaarNow was started by Priyanshu Jain, Arjun Harish, and Tarithmay Mandal, all former Zepto executives. Their roles weren’t random either. Jain worked in consumer strategy. Harish handled revenue planning, and Mandal worked on revenue pricing and customer strategy. That’s a sharp mix for a business where pricing, repeat behavior, assortment, and order density decide whether the model works or burns cash.

Why this team fits the problem

Jain studied at IIT Bombay, and Harish brings more than a decade of consumer-tech and operating experience. The fit is obvious. These are operators who’ve spent time inside one of India’s fastest-scaling quick commerce companies. They’ve seen the demand levers and the unit-economics pain up close.

That matters because BazaarNow isn’t trying to invent a new consumer category. It’s trying to rebuild the stack for a different user base. Jain’s own framing gets to the point: grocery shopping in tier-2 and tier-3 India is “more local, more habitual and much more value-conscious.” That’s not a minor insight. It changes merchandising and interface design. It also shapes delivery promises, and even whether discounts help or confuse the customer.

Traction and the round details

BazaarNow launched operations in January 2026 and has already scaled to more than 1,800 orders per day per store in its pilot city. On LinkedIn, the company lists itself at 11-50 employees and has been hiring for network expansion. The physical rollout is already underway.

Peak XV Partners led the ₹72 crore round, with participation from Whiteboard Capital and Antler. Angels in the round included Meesho founder Vidit Aatrey, AppsForBharat founder Prashant Sachan, Chaayos founder Nitin Saluja, Zeo Health co-founder Siddharth Gadia, FirstClub founder Ayyappan R, and other operators. ETStartup reported total funding to date at ₹80 crore including a pre-seed round.

BazaarNow will use the new capital for expansion, supply-chain strengthening, and technology. Peak XV’s Abhishek Mohan put the investment thesis plainly: the team isn’t just copying metro quick commerce into the rest of India, it’s building something more local and more disciplined. Investors aren’t paying for speed alone here. They’re paying for adaptation.

How BazaarNow compares with Blinkit and Instamart

Here’s the hard part. BazaarNow is entering a market where Blinkit, Zepto, and Swiggy Instamart already dominate mindshare, and where BB Now, Flipkart Minutes, and Amazon Now are also pushing in. Most of the big players were built around dense urban demand first. BazaarNow’s pitch is narrower and maybe smarter. Start with smaller cities. Keep pricing simple. Stock local assortments, and add assisted commerce instead of assuming every shopper wants a slick self-serve app.

The real incumbent, though, isn’t another app. It’s the kirana store and the familiar neighborhood buying habit. Mint reported that local grocers often stock around 1,000 items, while quick-commerce platforms can offer up to 8,000. But smaller-city customers still care a lot about value and routine. BazaarNow is trying to sit between those two worlds — more selection and convenience than a kirana, but more local feel than a metro-first quick commerce app.

Why BazaarNow funding matters for the next stage

This BazaarNow funding round gives the company something early-stage commerce startups rarely get enough of: time to build the boring parts properly.

Fresh produce is unforgiving. Smaller-city delivery is operationally messy. A vernacular-first product only works if inventory, search, routing, and rider operations all line up. So when BazaarNow says it will spend on supply chain and tech, that’s the core product.

It also tells you Peak XV isn’t chasing a vanity growth story. The fund is backing a startup with a clear wedge. It’s going after the next 700-plus Indian cities with a different service model. If BazaarNow can keep order density healthy while staying relevant to local buying habits, it won’t need to out-Blinkit Blinkit. It just needs to own a market others still treat as an extension of metro demand.

How big is the India quick commerce market outside metros?

India’s quick commerce market is no longer a niche side bet. Redseer pegged the category at $10 billion-plus in GMV with 30 million-plus monthly users in 2025. Its 2026 projections show the market reaching about $25 billion, with 50 million-plus average monthly transacting users and presence in 250-plus cities.

But the metros still dominate. Redseer’s 2026 data says the top 8 metros account for 70-75% of quick commerce activity, and its earlier work noted that 90-plus non-metro cities contribute just over 15% of GMV today. That gap is exactly why startups like BazaarNow exist. The upside is huge if somebody can crack demand aggregation, local assortment, and delivery economics outside the top urban clusters.

There’s another reason the timing makes sense. Quick commerce already commands roughly 70% of India’s online grocery market, yet online grocery itself is still only around 2% of total grocery retail. Redseer also estimates that 85-90% of mass grocery retail still runs through traditional trade. So yes, quick commerce is growing fast. But it has barely started to penetrate the broader grocery market — especially in Bharat.

Final take on BazaarNow funding

BazaarNow funding isn’t just another seed-to-Series-A style startup story with ex-unicorn operators and a fresh deck. It’s a bet that India’s next big grocery habit may be built outside the metros, with local language search, call-assisted ordering, cleaner pricing, and tighter supply execution. The next thing to watch is whether BazaarNow can turn that thesis into repeat behavior across multiple smaller-city clusters without losing the discipline that got Peak XV to write the check in the first place.

Read how Evotrex raised a $30M Series A to bring its hybrid RV trailer to market, combining battery power, solar energy, and onboard generation to make extended off-grid travel more practical and comfortable.

FAQ

• What funding did BazaarNow raise? BazaarNow raised ₹72 crore in a round led by Peak XV Partners. Whiteboard Capital and Antler also joined, along with angels such as Vidit Aatrey, Prashant Sachan, Nitin Saluja, Siddharth Gadia, and Ayyappan R; total funding to date is reported at ₹80 crore.
• How does BazaarNow’s quick commerce product work? BazaarNow runs a vernacular-first grocery app aimed at tier-2 and tier-3 users, with AI-powered local-language search and an in-house logistics system. It also supports assisted ordering, including call-to-order. That’s a useful tweak for households that want convenience without a fully self-serve app experience.
• Who founded BazaarNow? BazaarNow was founded in January 2026 by Priyanshu Jain, Arjun Harish, and Tarithmay Mandal, all former Zepto executives. Their backgrounds span consumer strategy, revenue planning, and pricing/customer strategy, which gives the team strong operating fit for quick commerce.
• Why are investors interested in tier-2 and tier-3 quick commerce now? Because the category is already large, but the next wave of growth hasn’t been won yet. Redseer projects India quick commerce at about $25 billion in 2026, while non-metro cities still contribute a relatively small share of GMV, leaving a lot of room for companies that can tailor assortment, pricing, and operations to local demand.

Evotrex builds a hybrid RV trailer designed to make extended off-grid camping feel less like compromise and more like actual comfort. The Los Angeles-based startup has now closed a $30 million Series A to push that vision closer to production. The bet is simple: a lot of RV buyers want longer stays away from hookups, but they also don’t want the range anxiety of an all-electric trailer or the clunky tradeoffs of traditional gas-powered systems. Founded in 2024 by Alex Xiao and a team with roots in Anker and the auto industry, Evotrex is trying to turn that gap into a real business.

And it’s moving fast.

The company is only 2 years old, yet it’s already talking about selling its first units in 2027 and eventually building around 1,000 trailers a year. That’s ambitious — maybe uncomfortably ambitious for a hardware startup in RVs, where durability problems can wreck a brand before it really starts. Evotrex is aware of that risk. That’s part of what makes this round worth watching.

What is the Evotrex hybrid RV trailer and how does it work?

The Evotrex PG5 is a power-generating travel trailer that runs primarily on electricity but carries its own backup generation system. Its setup combines a 43 kWh LFP battery pack and 1.5 kW of solar. It also uses regenerative braking and a 75 kW onboard gas generator that automatically recharges the pack when needed. Evotrex is pitching that as a way to keep HVAC, appliances, and onboard systems running much longer off-grid without depending on campground hookups or public charging.

That power story is only half the product. The PG5 also includes what Evotrex calls Active Power Assist, which is meant to reduce towing strain for both EVs and traditional trucks. The trailer supports remote-control parking with a bird’s-eye view. It uses air suspension and has one-touch auto-leveling instead of the usual manual routine that eats up time at the campsite.

Inside, the company is going for a tech-heavy, residential feel rather than classic RV minimalism. There’s a tablet-based control system for climate and lighting. Power management is built in. It also has bedroom smart dials, a roofed patio section, a dry bath with instant hot water, 2 queen-size beds, a full-size fridge, and 83.5 cubic feet of storage. Water capacity lands at 60 gallons fresh and 30 gallons each for gray and black tanks. That matters a lot more than splashy CES demos if people actually want to stay out for days.

The buying flow is already live in pre-production form. Evotrex is taking fully refundable $100 preorders, with initial availability aimed at the U.S., Canada, and Australia, and U.S. deliveries prioritized first. The base PG5 starts at $119,990. The Premium version tops out at $159,990.

Who founded Evotrex and why build a hybrid RV trailer?

Founding story

Evotrex didn’t come out of a conventional RV background. Alex Xiao said the idea started in 2021 while he was spending long stretches traveling in RVs through Tibet and other parts of China, and later doing hands-on RV market research across the U.S. That matters, because Evotrex’s pitch isn’t really “here’s a cooler camper.” It’s “here’s a trailer built around the power problem that keeps off-grid travel annoying.”

The founding team is broader than the source article suggests. Xiao is founder and CEO. Bruce Yang is co-founder and CTO. Jack Zhan is co-founder and COO. Stella Qin is co-founder and head of North America. That mix — product, automotive engineering, operations, and go-to-market — looks intentional for a company trying to ship a complicated hardware product instead of just showing one off.

Founder market fit

Xiao’s background is a big part of the story. He was Anker’s first product manager in 2011, spent more than a decade helping build the mobile charging giant, and played a major role in early portable power efforts there. Los Angeles Business Journal also reported that he started Anker Solix and managed a business worth about $600 million before leaving to build Evotrex.

The rest of the team isn’t filler. Bruce Yang came from Geely Group’s automotive R&D world, with experience tied to EV technology across a corporate family that includes Volvo, Polestar, and Lotus. Jack Zhan brings more than 20 years in manufacturing and procurement. He also worked on quality systems, with prior leadership roles at Anker, Lenovo, and IBM. Stella Qin previously led global brand teams at Anker, eufy, and Anker Solix.

That’s probably why Xiao sounds pretty calm about the crowd forming around electric and electrified RVs. “We are not afraid of competition, competition is a good thing. We educate the market together, we grow the market together,” he told TechCrunch. It’s a fair line. But it’s only convincing if the company can execute on product quality, service, and supply chain all at once.

Traction, fundraising, and competition

So far, Evotrex has validated a functional version of the PG5, but wants another 10 to 12 months for durability testing before full commercialization. The startup emerged from stealth in November 2025 and showed the PG5 at CES 2026. One early signal stands out: Xiao said the company hired its first service employee about 6 months ago, while its first sales employee joined only recently. That’s not glamorous. It’s also probably the sane move in RVs.

The fundraising picture is starting to match the ambition. This new $30 million Series A brings total funding to $46 million. Much of the round came from Chinese and Hong Kong-based investors including GSR United Capital, Forebright Concerto Capital, TTGG Ventures, and Pegasus Capital. Anker was already involved as a seed investor. Evotrex says the money will help finish testing and prepare production. It will also support a manufacturing plan that still calls for core manufacturing in China with final assembly in California.

The startup also says 90% of its current order book is for the fully loaded Premium trim, priced at around $160,000. That’s a useful signal, though it also tells you exactly who the first customer is: not the average weekend camper, but a buyer willing to pay real money for off-grid tech and convenience.

Competition is real, and it’s getting more serious by the month. Lightship raised a $34 million Series B in January 2024 to bring its all-electric L1 trailer to market, while Pebble showed the production-intent Pebble Flow at CES 2025 and began production in April 2025. Both are pushing fully electric trailers. Legacy players are slower. Thor’s early electric product strategy has leaned toward fleets, and Winnebago’s eRV2 has been in testing since 2023. Evotrex’s angle is different: it’s selling a hybrid answer to a market where pure electric still leaves a lot of buyers wondering how long they can stay out there before the math stops working.

Why are investors backing Evotrex now?

Because this round is less about concept validation and more about crossing the ugly middle stage between prototype buzz and actual deliveries.

RV startups don’t fail because the renderings are bad. They fail because build quality slips and service breaks down. Manufacturing also takes longer than planned. Xiao’s emphasis on durability testing and after-sales support suggests Evotrex understands that. Frankly, investors probably liked hearing that more than another pitch about “redefining adventure.”

There’s also a clear roadmap behind the money. Evotrex needs to finish engineering validation and lock down its China manufacturing and California assembly footprint. Then it has to prepare for first commercial shipments after production begins. If the company can hit those steps, the $30 million round stops looking like hype capital and starts looking like bridge capital.

Then there’s the team. A startup staffed with people from Anker, Geely, Lenovo, IBM, and EV-adjacent consumer tech is easier to underwrite than one built purely around RV enthusiasm. That doesn’t guarantee success. But it helps explain why investors are willing to back a hardware-heavy bet in a category that’s notoriously unforgiving.

How big is the hybrid RV trailer market?

The broad RV market is still large enough to matter. U.S. RV shipments totaled 342,220 units in 2025, according to RV Industry Association data, and travel trailers alone accounted for 237,631 of those shipments. That means Evotrex isn’t trying to create demand from scratch. It’s trying to win a premium slice of an already massive category.

What’s changing is the kind of product buyers will consider. Power has become a bigger part of the value proposition, not just an accessory. People want residential comforts off-grid. EV owners want less towing penalty. Startups like Lightship, Pebble, and Evotrex are all attacking the same friction point from different directions. All-electric efficiency sits on one side. Hybrid endurance sits on the other.

Should buyers watch Evotrex’s next hybrid RV trailer milestone?

Yes — but not because of the fundraising headline.

The real test for this hybrid RV trailer company starts after CES buzz fades and preorder curiosity cools off. Over the next 12 months, the things that matter are durability, service readiness, final assembly execution, and whether Evotrex can turn its power-first idea into a product people trust enough to actually use far from hookups. If it does, the PG5 could end up carving out a very real lane between old-school gas RVs and the first wave of all-electric trailers.

Read how Immuneel Therapeutics raised over ₹100 crore in a Series B round to expand access to CAR-T cancer therapies in India and build a broader cell and gene therapy platform for advanced blood cancer treatment.

FAQ

• What funding did Evotrex raise?
  Evotrex raised a $30 million Series A in June 2026, bringing total funding to $46 million. The round included firms such as GSR United Capital, Forebright Concerto Capital, TTGG Ventures, and Pegasus Capital, while Anker had already backed the company earlier through its seed financing.
• How does the Evotrex PG5 hybrid RV trailer work?
  The PG5 is an electrified travel trailer that uses a battery-first setup and then recharges itself with an onboard gas generator when needed. Its system combines a 43 kWh battery and solar input. It also uses regenerative braking and a 75 kW generator so the trailer can keep powering onboard systems during longer off-grid stays.
• Who founded Evotrex?
  Evotrex was founded in 2024 by Alex Xiao along with Bruce Yang, Jack Zhan, and Stella Qin. Xiao came from Anker, where he was an early product leader, while the rest of the founding group brought experience in automotive R&D, manufacturing, and consumer tech brand building.
• Is Evotrex part of the electric RV market or the traditional RV market?
  It sits somewhere in between, and that’s the point. Evotrex is selling a hybrid RV trailer — not a conventional gas trailer and not a pure EV trailer — which puts it in the emerging electrified RV category alongside startups like Lightship and Pebble, but with a longer-range off-grid pitch built around onboard generation.

Immuneel Therapeutics builds personalized cell and gene therapies for cancer, and it has now raised over ₹100 crore in a Series B round to scale that effort. The company is tackling a brutal problem: advanced blood-cancer treatment is still scarce and expensive in India, especially when therapies depend on specialized manufacturing and tightly controlled hospital delivery. Founded in 2018 in Bengaluru by Biocon founder Kiran Mazumdar-Shaw alongside Siddhartha Mukherjee and Kush M. Parmar, the company is trying to turn one approved CAR-T product into a broader cross-border platform. The new round brought in Singularity AMC, Rainmatter by Zerodha, high-net-worth individuals, and existing backers including Mazumdar-Shaw, Eight Roads Ventures, and F-Prime Capital.

What does Immuneel Therapeutics actually do?

Immuneel Therapeutics develops and manufactures CAR-T cell therapies — a type of personalized immunotherapy in which a patient’s own T-cells are collected and genetically modified to recognize cancer. The cells are expanded in the lab and then infused back into the patient. In Immuneel’s treatment flow, the patient is first screened and registered at a qualified center, then undergoes leukapheresis. After that, the cells are sent to Immuneel’s lab for manufacturing. Patients then receive lymphodepletion chemotherapy and CAR-T infusion across 3 different days. Post-infusion monitoring and follow-up come next. The manufacturing step takes about 4 weeks on average, and post-infusion hospitalization can run 3 to 4 weeks depending on the clinical course.

Its commercial product is Qartemi, or varnimcabtagene autoleucel, an autologous second-generation CD19 CAR-T therapy for relapsed or refractory B-cell Non-Hodgkin lymphoma in adults. In plain terms, Immuneel is working with the patient’s own cells and targeting CD19 on malignant B-cells. It uses a 4-1BB co-stimulatory domain. The company says the manufacturing process selects CD4 and CD8 T-cells. It also uses IL-7 and IL-15 to improve persistence. Qartemi is delivered in 3 fractions — 10%, 30%, and 60% — rather than one single dump dose. That design choice matters in a category where safety management is critical.

And this isn’t just a science story. A lot of the heavy lifting in CAR-T is boring, operational stuff. That’s where companies fail. Immuneel says Qartemi is manufactured on the Miltenyi CliniMACS Prodigy platform, a closed GMP system, with multi-step quality control. It uses GMP-grade raw materials and cryogenic transport in liquid-nitrogen vapor phase at -150°C. The company also highlights chain-of-custody and chain-of-identity controls. Those are non-negotiable when every batch belongs to one specific patient.

Before CAR-T, the patient path often meant more chemotherapy, more waiting, and a decent chance of running out of useful options. Immuneel’s pitch is a cleaner, structured pathway: one personalized manufacturing cycle and a planned infusion. Close monitoring follows, then long-term follow-up if the therapy works. That doesn’t make it simple. But it does make the process more standardized than the old “try the next line and hope” routine.

Who founded Immuneel Therapeutics and why?

The founding story

Immuneel was founded in 2018 in Bengaluru by Kiran Mazumdar-Shaw, Siddhartha Mukherjee, and Kush M. Parmar. That lineup says a lot about the company’s DNA right away: biotech scale-up and frontline oncology thinking. It also brings venture-backed drug-development discipline. The original idea was clear too — advanced cell therapies shouldn’t be limited to a handful of rich markets and a tiny slice of patients.

Why the founders actually fit this category

Mazumdar-Shaw brings the industrial side. She founded Biocon in 1978, started the company from a garage in India, and has spent more than 4 decades building biotech businesses around affordable access and scaled manufacturing. If you were going to bet on an Indian founder to take a hard, process-heavy therapy and make it manufacturable locally, she’d be on a very short list.

Mukherjee brings the cancer lens. He’s a Columbia physician and a translational medicine researcher. He’s also a scientific co-founder of Vor Biopharma and a Pulitzer-winning author with deep credibility in oncology. Parmar adds the company-building and capital-markets side as managing partner at 5AM Ventures, with board roles across Akouos, Homology Medicines, Rallybio, and Vor Biopharma. The current operating layer matters too. CEO Amit Mookim is described as a business leader focused on healthcare access, while Dr. Lakshmikanth Gandikota has led multiple IND, BLA, and MAA approvals in biologics and cell and gene therapy.

What traction does Immuneel Therapeutics already have?

Immuneel is still a clinical-stage biotech, but it’s no longer a concept deck. Qartemi was commercially launched in January 2025, and the company’s pipeline page ties the product back to its collaboration with Hospital Clínic Barcelona, where varnimcabtagene autoleucel was already approved in Spain. Immuneel says Qartemi achieved 100% manufacturing success during the IMAGINE clinical trial in India. That’s the kind of operating metric investors watch closely in cell therapy. By August 2025, the company was already talking about two-year remission in blood-cancer patients. It wants to sell durability, not just approval.

How was the round structured?

This new round is a Series B of more than ₹100 crore. New participants include Singularity AMC, Rainmatter by Zerodha, and high-net-worth individuals, while existing investors Kiran Mazumdar-Shaw, Eight Roads Ventures, and F-Prime Capital also joined. Immuneel had previously announced a $15 million Series A in June 2022 alongside the start of Phase II patient trials. The fresh money is earmarked for expanding GMP manufacturing capacity and advancing its next-generation deep-tech pipeline toward clinical milestones. It will also support Qartemi’s commercial rollout and push into Asia Pacific and the Middle East.

Mazumdar-Shaw framed the round like this: “This company was founded with the belief that advanced cell therapies should not remain confined to a small segment of patients or a handful of geographies. This fundraise strengthens our ability to build a globally competitive CAR-T platform from India combining deep science, scalable manufacturing and significantly improved affordability. We believe India can play a meaningful role in shaping the future of cell and gene therapy for the world.”

CEO Amit Mookim was even more direct: “Qartemi’s commercialisation proved we can deliver world-class CAR-T outcomes at a fraction of Western costs. This Series B financing accelerates what comes next: a bold international expansion and a next-generation pipeline that will redefine how cell therapies reach patients globally. We are not just building a company—we are building a new global standard of care, from India.”

How does Immuneel compare with rivals?

In India, the closest direct reference point is ImmunoACT, the IIT Bombay-incubated company behind NexCAR19, which positions itself as India’s first approved CAR-T therapy. Outside India, the benchmark is older and much larger: Novartis with Kymriah, Kite with Yescarta, and Bristol Myers Squibb with Breyanzi all market approved CAR-T products for B-cell malignancies. Those aren’t identical competitors on geography or pricing. But they are the global standard any serious CAR-T company gets measured against.

The legacy alternative is still salvage chemotherapy or stem-cell-transplant pathways for relapsed or refractory lymphoma. Immuneel’s differentiation isn’t that it invented CAR-T. It’s trying to industrialize it in India with local manufacturing and integrated GMP processes. Controlled logistics are part of that. So is pricing that lands at a fraction of western cost. That’s what investors are backing here — not just a drug, but a delivery and manufacturing model that could travel across emerging markets.

Why does Immuneel Therapeutics funding matter?

Because cell therapy companies don’t scale on ambition alone. They scale on clean rooms and manufacturing slots. Release testing matters too. So do logistics, trained treatment centers, and the ability to keep all of that synchronized. When Immuneel says it will use this round to expand GMP manufacturing capacity, that’s the bottleneck. More capacity can mean more treated patients, fewer scheduling constraints, and a more credible commercial launch.

The round also matters because Immuneel is trying to graduate from “one approved product” to “platform company.” The money is going into a next-generation pipeline, not just Qartemi. Its recent 2026 announcements point the same way. Those include a partnership with Impact Guru and CarePal Money to improve financial access, plus work with Manas AI around next-generation biologics and in-vivo gene-based therapies.

There’s also a strategic signal in the geography. Asia Pacific and the Middle East aren’t random add-ons. They’re regions where cost, access, and local treatment infrastructure can decide whether advanced therapies become real businesses or stay prestige medicine for a few hospitals. Immuneel thinks India can be both the manufacturing base and the price-performance argument. That’s ambitious. It’s also a lot more believable now than it was 3 years ago.

How big is the CAR-T therapy market?

The macro setup is real. Grand View Research estimates the global cell therapy market was worth $4.74 billion in 2023 and projects it will reach about $20.07 billion by 2030, which implies a 22.66% CAGR. That kind of growth doesn’t mean every CAR-T startup wins. It does mean investors still see advanced therapies as a long-cycle category worth funding through manufacturing pain and regulatory complexity.

India’s cancer burden makes the access argument even harder to ignore. Government material released in early 2025 put the number of cancer incidences in India at more than 14 lakh in 2023, and earlier ICMR work had already projected a 12% rise in cases by 2025. Not all of those patients are CAR-T candidates, obviously. But a rising oncology burden creates pressure for more domestic high-end treatment capacity, especially in blood cancers where relapse can leave patients with very few good options.

There’s another shift underneath this. Cell and gene therapy used to be discussed almost entirely as a western pharma story. That’s changing as Asian companies build manufacturing expertise and academic-origin programs mature into commercial products. Regulators are getting more comfortable with advanced therapies too. Immuneel’s timing makes sense in that context — not because the risks are gone, but because the infrastructure gap is finally narrow enough to attack.

Where Immuneel Therapeutics goes next

Immuneel Therapeutics now has to prove that its pitch works outside a fundraising headline. Can it expand manufacturing without compromising turnaround times and move from early commercial traction to repeatable hospital adoption? Can an India-built CAR-T platform cross borders into Asia Pacific and the Middle East without losing speed on compliance and delivery?

That’s the part worth watching.

Read how GPS Renewables raised ₹635 crore to scale its bioenergy infrastructure business, converting organic waste into compressed biogas, renewable natural gas, and other low-carbon fuels through an integrated platform spanning engineering, EPC, operations, and project development.

FAQ

• What is the latest funding round for Immuneel Therapeutics?
  Immuneel Therapeutics has raised over ₹100 crore in a Series B round. The investors named in the round include Singularity AMC, Rainmatter by Zerodha, high-net-worth individuals, and existing backers such as Kiran Mazumdar-Shaw, Eight Roads Ventures, and F-Prime Capital.
• How does Qartemi CAR-T therapy work?
  Qartemi is an autologous CD19 CAR-T therapy, which means it uses a patient’s own T-cells to attack B-cell lymphoma. The process typically starts with leukapheresis and moves into roughly 4 weeks of lab manufacturing. It then goes through lymphodepletion chemotherapy, infusion over 3 days, and close hospital monitoring afterward.
• Who founded Immuneel Therapeutics?
  Immuneel Therapeutics was founded in 2018 by Kiran Mazumdar-Shaw, Siddhartha Mukherjee, and Kush M. Parmar. That’s a rare mix of biotech operating experience and oncology research credibility. It also brings venture-backed life-sciences expertise, which is why the company has looked more serious than a typical early-stage biotech from day 1.
• Is CAR-T therapy becoming a bigger market in India?
  Yes. India’s cancer burden keeps rising, while the global cell therapy market is projected to grow from $4.74 billion in 2023 to about $20.07 billion by 2030. That creates room for local manufacturers that can lower cost and build treatment capacity closer to patients.

GPS Renewables builds plants that turn organic waste into compressed biogas, renewable natural gas, ethanol, and other low-carbon fuels. The latest GPS Renewables funding round brings in ₹635 crore for the Bengaluru company as it pushes harder into large-scale bioenergy infrastructure. India has tons of feedstock for clean fuels, but converting waste into bankable, operating projects is still messy, capital-heavy work. Founded in 2012 by Mainak Chakraborty and Sreekrishna Sankar, GPS Renewables has spent more than a decade trying to solve that execution problem.

What does GPS Renewables actually do?

At a basic level, GPS Renewables designs and delivers systems that take organic waste streams, process them through anaerobic digestion and gas-cleaning steps, and turn that output into usable clean fuels such as RNG and CBG. It doesn’t just sell one reactor or one filter. The company spans process design and engineering. It also handles EPC, operations, maintenance, and project development across the biofuel chain.

Its product stack is more specific than the usual “waste-to-energy” label suggests. BioUrja is the company’s flagship decentralized biogas system for on-site organic waste processing, aimed at turning food and other organic waste into fuel where it is generated. OptiMaxx covers core plant hardware and subsystems such as VPSA tanks, gas distribution systems, and heat exchangers. GPS also works on gas purification and control technology for biogas upgrading.

This cuts out a lot of fragmented manual work. A customer doesn’t have to separately find a digestion technology vendor, then an EPC contractor, then a purification specialist, then an operator who can keep gas quality stable. GPS has built around that gap. Investors keep backing it because bioenergy projects usually fail less on concept and more on integration.

The company’s product thinking was shaped early by practical constraints, not lab theory. Mainak Chakraborty and Sankar had to make systems smaller for urban sites, reduce odor, make waste feeding less messy, build vertically where land was tight, and monitor plant health remotely. Their first commercial pilot came through Akshaya Patra. That gave them an operating test bed instead of a slide deck.

Who founded GPS Renewables and what has it built?

How the company started

GPS Renewables was founded in 2012 by Mainak Chakraborty and Sreekrishna Sankar, both IIM Bangalore alumni. The starting point was pretty simple: Bengaluru’s waste problem was obvious, ugly, and underserved by practical technology. Chakraborty had skipped campus placements because he wanted to build an environment-focused business, and he and Sankar turned that instinct into a company built around compact biowaste-to-energy systems.

Why the founders fit this market

Chakraborty is the public face of the business and has long had credibility in climate tech circles. MIT Technology Review recognized him as one of its Top Innovators Under 35 in 2013, and the World Economic Forum also named him a Global Shaper. Sankar brought a different skill set: software consulting experience at Oliver Wyman, deep technical roots through the Free Software Foundation of India, and advisory work with Kerala’s Suchitwa Mission on waste management. That mix matters. Bioenergy isn’t just chemistry or infra finance. It needs both systems thinking and operational grit.

What GPS Renewables has already executed

This isn’t an early prototype story anymore. GPS Renewables now has more than 800 employees and annual revenue of about ₹1,000 crore. It has over 30 operational or near-complete projects and has visibility on more than 200 CBG projects with oil marketing companies, plus landmark installations including the municipal solid waste-based CBG plants in Indore and Barabanki.

It has also moved beyond biogas into adjacent clean-fuel bets. Most recently, it won the EPC contract from NTPC for India’s first Ethanol-to-Jet sustainable aviation fuel plant.

Funding details and where the money goes

The ₹635 crore Series C is structured in layers. PixelSky Capital led ₹125 crore of equity, with Spectrum Impact Family Office and other investors joining in. GPS also tied up ₹200 crore in equity for its asset platform, Arya, from a leading Korean conglomerate, following an earlier ₹310 crore investment from Sojitz Corporation tied to the asset-platform business. The new money will support the next growth phase, expand its bioenergy infrastructure portfolio, and fund ongoing and upcoming projects through GPSR Arya.

There’s some useful context here too. GPS Renewables had already raised $20 million in Series B funding in 2022 from Neev Fund II, Hivos-Triodos Fund, and Caspian Impact Investments. It then added $50 million in debt financing in April 2024 to speed up nationwide CBG and RNG rollout. Arya itself was launched in 2022 to develop build-own-operate renewable energy assets. That shows the company doesn’t want to stop at being a contractor. It wants infrastructure upside as well.

Competition and where GPS sits

In India, GPS Renewables is up against both technology-led bioenergy players and project developers. Praj Industries is the obvious benchmark on process technology and plant engineering, with its own CBG platform and more than 40 industrial renewable gas installations. EverEnviro is another serious name on the asset-development side, targeting more than 100 CBG plants and 1,000 metric tons per day of CBG output over five years.

GPS is trying to sit in a harder-to-copy middle ground. Legacy alternatives often look fragmented — one vendor for digestion, another for gas cleaning, another for EPC, then someone else for operations. GPS combines technology and engineering. It also brings project execution, and now capital through Arya. The company also has joint-venture ties with Indian Oil and BPCL, which gives it a distribution and offtake edge many smaller builders don’t have.

Why does this GPS Renewables funding round matter?

Because this round gives GPS more room to behave like an infrastructure company, not just a cleantech vendor.

That matters. EPC businesses can grow fast, but they’re working-capital hungry and exposed to project delays. An asset platform changes the earnings profile if it works, since owning or co-owning projects can create longer-duration cash flows. Arya is the clearest signal that GPS wants that second act.

The investor mix says something too. PixelSky didn’t back a moonshot science project. It backed a company that investors describe as profitable, disciplined, and strong on execution. Mainak Chakraborty framed the round as a vote of confidence in renewable natural gas, while Parag Parikh said it will strengthen the balance sheet and support capital management across both EPC and asset businesses. GPS now has the money to take on a larger pipeline without stretching itself too thin.

How big is the market behind GPS Renewables funding?

The demand story is real, even if the buildout is slower than the slogans. India’s SATAT initiative, launched in October 2018, envisioned 5,000 CBG plants producing 15 million metric tons per year. By May 2026, only about 206 plants were operational despite more than 3,600 project approvals. That gap tells you two things at once: the market is huge, and execution is still hard.

The IEA still sees a strong runway. In its 2026 India Bioenergy Market Report, it said India had around 170 functional CBG plants by 2025 with almost 300 more under construction. It also forecast liquid and gaseous biofuels to grow from 293 petajoules in 2025 to 429 petajoules by 2030 in its main case. A separate IEA-linked summary noted combined biogas and CBG supply could grow 53% between 2025 and 2030, with CBG alone rising more than seven-fold under the main-case timeline.

That’s the setup for companies like GPS. Feedstock exists. Policy intent exists. Oil and gas buyers exist. What’s missing is reliable conversion of those ingredients into running plants with stable gas yields, bankable economics, and long-term operations.

Conclusion

GPS Renewables funding isn’t just another climate-tech headline. It’s a bet that India’s bioenergy push will be won by companies that can engineer, finance, build, and operate actual projects — not just talk about circular economy theory. The next thing to watch is whether Arya turns GPS from a strong EPC player into a genuine owner of renewable gas infrastructure.

Read how Innefu Labs raised a $30M Series B from Panthera Growth Partners to expand its AI-powered national security, cyber defense, and investigative intelligence platform, helping governments and enterprises reduce reliance on foreign systems and strengthen sovereign technology capabilities.

FAQ

• What is the latest GPS Renewables funding round? GPS Renewables has raised ₹635 crore in a Series C round announced on June 8, 2026. The package includes ₹125 crore led by PixelSky Capital, plus capital lined up for Arya from a Korean conglomerate after an earlier Sojitz-backed commitment to the asset platform.
• How does GPS Renewables turn waste into fuel? It builds systems that process organic waste through anaerobic digestion and gas-upgrading steps to produce CBG and other clean fuels. The company also supplies supporting plant hardware. It handles the engineering, construction, and operating side too, which matters in a category where projects usually break at the handoff points.
• Who founded GPS Renewables? GPS Renewables was founded in 2012 by Mainak Chakraborty and Sreekrishna Sankar, both IIM Bangalore alumni. Chakraborty came in wanting to build an environment-focused business, while Sankar brought consulting and waste-management experience that fit the company’s operating model from the start.
• Why are investors interested in the compressed biogas market in India? Because India has a large waste feedstock base, a policy push behind CBG, and rising interest from oil marketing companies that need cleaner fuel supply. The catch is execution, which is why firms that can actually commission and run plants — not just license technology — are drawing capital now.